[Table/Fig-2]:

Association of miRNAs with early stages of cervical cancer.

miRNA gene polymorphisms	Controls	Early stages (I+II) n(%)	p-value	OR* (95%CI)
miRNA 146a
GG	84 (51.2%)	37 (44.04)	-	Reference
GC	72 (43.9%)	38 (45.23)	0.204	1.440 (0.820-2.529)
CC	8 (4.87%)	9 (10.71)	0.067	2.55 (0.91- 7.14)
miRNA 196a2
CC	21 (12.8%)	11 (13.09%)	-	Reference
CT	81 (43.9%)	46 (54.76%)	0.381	1.296 (0.726-2.314)
TT	62 (37.8%)	27 (32.14%)	0.688	1.193 (0.505-2.816)
miRNA 499
CC	34 (20.73%)	37 (44.04%)	-	Reference
TC	76 (46.34%)	37 (44.04%)	0.008	2.984 (1.331 – 6.691)
TT	54 (32.92%)	10 (11.90%)	0.001	6.488 (2.780 – 15.140)

*OR = odds ratio